Next Article in Journal
Temporal Dynamics of Purinergic Receptor Expression in the Lungs of Marek’s Disease (MD) Virus-Infected Chickens Resistant or Susceptible to MD
Previous Article in Journal
Naturally Derived Terpenoids Targeting the 3Dpol of Foot-and-Mouth Disease Virus: An Integrated In Silico and In Vitro Investigation
Previous Article in Special Issue
Role of miRNA in Highly Pathogenic H5 Avian Influenza Virus Infection: An Emphasis on Cellular and Chicken Models
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Exploring Potential Intermediates in the Cross-Species Transmission of Influenza A Virus to Humans

by
Chung-Young Lee
1,2
1
Department of Microbiology, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea
2
Untreatable Infectious Disease Institute, Kyungpook National University, Daegu 41944, Republic of Korea
Viruses 2024, 16(7), 1129; https://doi.org/10.3390/v16071129
Submission received: 25 June 2024 / Revised: 8 July 2024 / Accepted: 12 July 2024 / Published: 14 July 2024
(This article belongs to the Special Issue Advances in Animal Influenza Virus Research: Third Edition)

Abstract

:
The influenza A virus (IAV) has been a major cause of several pandemics, underscoring the importance of elucidating its transmission dynamics. This review investigates potential intermediate hosts in the cross-species transmission of IAV to humans, focusing on the factors that facilitate zoonotic events. We evaluate the roles of various animal hosts, including pigs, galliformes, companion animals, minks, marine mammals, and other animals, in the spread of IAV to humans.

1. Introduction

Influenza A virus (IAV) is a significant pathogen that primarily causes respiratory illnesses in humans [1]. Since its identification, IAV has been recognized as a major pathogen responsible for several notable pandemics in the 20th and 21st centuries, including the 1918 Spanish flu, the 1957 Asian flu, the 1968 Hong Kong flu, and the 2009 H1N1 pandemic [1,2]. These events underscore the virus’s capacity to cause widespread illness and significant mortality, emphasizing its critical impact on global public health.
Wild waterfowl are considered natural reservoirs of IAV, as the most diverse subtypes of the virus have been detected in these birds [3]. The segmented genome of IAV allows for frequent genetic exchange between different virus strains, leading to substantial viral diversity. This genetic reassortment, particularly during the co-infection of different IAV subtypes in the same host, accelerates the emergence of novel IAVs capable of infecting new hosts [4]. For example, the 2009 H1N1 pandemic virus (pdm09) emerged through reassortment events between human, swine, and avian IAVs [2,4]. Pigs played a crucial role in the genesis of pdm09 and its transmission to humans, underscoring the significant role of intermediate hosts in the emergence of new pandemics.
Potential intermediate hosts, such as pigs, poultry, and other animals, may serve as bridge hosts in the cross-species transmission of IAVs [4,5,6,7,8]. Similar to the case of SARS-CoV-2, where unknown intermediate hosts were vital for the virus’s adaptation and spread in humans [9], IAVs also rely on intermediate hosts to bridge transmission from their natural reservoirs to humans [6,7,8]. This review explores potential intermediate hosts of IAVs and evaluates their roles in cross-species transmission, focusing on the factors that facilitate zoonotic events.

2. Essential Factors for Zoonotic Events of IAVs

2.1. The Nature of the Relationship between Animals and Humans

Since their initial domestication approximately 15,000 years ago, animals have maintained a multifaceted relationship with humans. This relationship extends beyond mere companionship, encompassing critical roles such as providing sustenance and serving as transportation partners. However, this close association also carries inherent risks, particularly when it comes to the transmission of pathogens. As agricultural practices have advanced, the crowding of animals in confined spaces—often driven by profit maximization—has fostered an environment conducive to rapid pathogen spread and evolution. This intensified interaction between animals and humans raises the potential for zoonotic spillover events [10,11,12].
Individuals who work closely with infected animals face heightened exposure to animal-origin pathogens [13]. While most zoonotic spillovers are dead-end events, occasional establishment of stable host–virus interactions occurs. Additionally, companion animals—those with both physical and emotional proximity to humans—may serve as conduits for pathogen transmission to their owners. In light of these complexities, assessing the degree of interaction between animals and humans becomes crucial for predicting and preventing zoonotic spillover events.

2.2. Receptor Binding Specificity

Receptor binding specificity is crucial for IAV attachment to novel host cells, determining its host range and transmissibility. The α2,3 and α2,6 sialic acid linkages are key determinants of IAV host specificity [14,15]. Traditionally, human-adapted IAVs preferentially bind to α2,6-linked sialic acids (α2,6-SA) found predominantly in the human upper respiratory tract, facilitating efficient transmission [16,17,18]. In contrast, avian IAVs bind to α2,3-linked sialic acids (α2,3-SA), which are prevalent in avian respiratory tracts. The structural differences in the hemagglutinin (HA) protein of IAV account for these specific binding preferences, which are major determinants of the virus’s ability to infect different host species. However, more recent studies revealed that humans also have α2,3-SA in their lower respiratory tracts and that avian species have varied distributions of α2,3- and α2,6-SA glycans [16,19,20,21]. Moreover, the diversity of sialic acid-containing glycans in the respiratory tract has complicated the understanding of receptor binding specificity for IAVs of different origins [22].
Specific mutations in the receptor binding domain (RBD) of the HA protein, such as E190D/G225D in H1 or Q226L/G228S in H2 and H3 HAs, can increase binding affinity for α2,6-SA, aiding the adaptation of avian IAVs to human hosts [7,23,24,25,26,27]. This enhances the virus’s ability to attach to and enter human respiratory epithelial cells, increasing its transmissibility. Additionally, an optimal balance between HA receptor-binding avidity and neuraminidase (NA) receptor-destroying activity is essential for efficient viral entry and budding, related to efficient transmission between humans [7,28,29]. NA cleaves sialic acids from glycoproteins, facilitating the release of newly formed virions from infected cells.
NA also functions as a secondary receptor binding protein, aiding in the initial attachment of the virus to host cells [30,31,32]. Traditionally known for its role in cleaving sialic acid residues to facilitate viral release, NA’s binding capabilities enhance viral attachment, particularly when HA binding is suboptimal. A second sialic acid-binding site (2SBS) is at the loops of 368–370 and 399–403 in the NA, and it interacts with sialic acid receptors [30,33]. The sequence of 2SBS is preserved in avian IAVs but missing in human or swine IAVs [30,32,34]. This dual functionality of NA contributes to the efficiency of viral entry and subsequent infection, emphasizing the importance of the HA-NA balance in viral transmission and adaptation.

2.3. Acid Stability and Viral Transmission

The acid stability of the HA protein is another critical factor influencing IAV transmission. Respiratory viruses, including IAV, are primarily transmitted through contact, fomites, or airborne routes [35]. Viral transmission via aerosolized droplets produced by speaking, coughing, or sneezing is particularly concerning, as these droplets can widely disperse and infect susceptible individuals at a distance [36].
Studies have shown that IAVs with increased acid stability are likely to be more airborne transmissible in humans [37,38,39,40,41]. In 2012, highly pathogenic avian H5N1 IAVs that are capable of droplet transmission in ferrets were experimentally generated during adaptation in the ferret animal model [42,43]. Notably, these mutant viruses acquired mutations located in the vicinity of the fusion peptide in HA, increasing the acid and thermal stability of the mutant viruses, which is thought to enable droplet transmission of the mutant viruses in ferrets [42,43,44]. The environment of the human respiratory tract, which is slightly acidic (pH 5.5–6.5), can induce acid-induced conformational changes in IAV, leading to viral inactivation before receptor binding [45]. However, IAVs adapted to humans, such as the pdm09 H1N1 virus, have HA proteins with lower activation pH, enhancing their stability and transmissibility in the human respiratory tract [46]. The pdm09 H1N1 virus adapted to human hosts from pigs, and it was suggested that an HA activation pH of 5.5 or less is one of the requirements of pandemic IAVs [38]. Indeed, the HA activation pH of human-adapted IAVs tends to range from pH 5.0 to 5.5, in contrast to animal-origin IAVs retaining a broader range of HA activation pH [39,47]. Therefore, the host-specific optimality in acid stability of IAV seems to be deeply associated with viral transmission and replication in the host [39].

2.4. Permissiveness to a Novel Host

Mutations in both the HA and NA proteins, crucial for virus entry and budding, as well as mutations in the viral RNA polymerase, are essential for the adaptation of avian IAVs to human hosts [48]. Among these adaptations, the glutamate-to-lysine substitution at position 627 (E627K) or the aspartate-to-asparagine substitution (D701N) in the PB2 protein have been well-documented as viral adaptive mutations for mammalian hosts [48,49,50,51,52]. The 2009 H1N1 pandemic IAVs, resulting from multiple reassortment events between avian, swine, and human IAVs, retained 627E and 701D residues but acquired alternative mutations in the PB2 protein (G590S and Q591R) in the vicinity of residue 627 [53]. These mutations enabled efficient replication of pdm09 in both humans and pigs, playing a pivotal role in viral adaptation. Additionally, several other mutations in the polymerase genes contribute to the fine-tuning of viral host specificity [54,55,56,57,58]. The NS1 protein, an antagonist of the host’s innate immune response, is also known to be one of the determinants affecting viral replication, adaptation, and transmission in a novel host [59,60,61,62]. Specifically, the C-terminal region of the NS1 protein contains the PDZ-binding motif. Sequence differences in the PDZ-binding motif, dependent on the host of origin, are recognized as significant virulence determinants of IAV [61,62].
These host-determining mutations can interfere with the interaction between viral proteins and host factors differing by species. The acidic nuclear phosphoprotein-2 (ANP32) family of proteins is regarded as key species-specific host factors. ANP32 proteins form a complex with the viral polymerase complex and enable efficient cRNA-to-vRNA replication in a species-specific manner [48,63,64,65]. RNA polymerases from avian IAVs replicate their genome inefficiently due to species-specific differences in ANP32. However, host-adaptive mutations, such as E627K in the PB2 protein, allow avian IAV to replicate efficiently in the presence of human ANP32A [63,64]. In addition, several adaptive mutations in vRNA modulate the sensitivity of IAVs to certain human interferon-stimulated genes (ISGs), including RIG-I and MxA, overcoming the human innate immune response for efficient viral replication [66,67,68].

3. Animal Hosts of IAV Raising a Zoonotic Potential

3.1. Pigs

Pigs play a crucial role as hosts for influenza A viruses, acting as mixing vessels [69]. However, solid evidence supporting the mixing vessels model is somewhat lacking. Generally, sialic acid receptor distribution in the swine respiratory tract is similar to that of humans. The distribution of α2,6-SA glycan is higher than that of α2,3-SA glycan in the upper respiratory tract of pigs, and both glycans are comparably distributed in the lower respiratory tracts such as bronchiole and alveolar regions [70,71].
Throughout history, co-infections of human, swine, and avian IAVs in pigs have resulted in the emergence of multiple reassortment viruses. Notably, the 2009 H1N1 pandemic virus (pdm09) originated from such reassortments [72,73]. The H1N1/pdm virus has successfully adapted to humans and now causes seasonal epidemics, underscoring the pivotal role of pigs as intermediate hosts in IAV pandemics [72,74,75].
The optimum HA activation pH of swine IAVs is known to retain a broader range, ranging from pH 5.0 to 6.3 [47,76]. The early H1N1/pdm virus, A/California/04/2009, showed a fusion pH of 5.5, while a more recent H1N1 virus mediated membrane fusion at pH 5.3 [38]. This suggests that a reduction in fusion pH may be necessary for further adaptation of swine IAVs to actively spread among human populations. In the context of mutations for replication in mammalian hosts, swine IAVs seem to utilize a similar but distinctive adaptation pathway compared to human IAVs. The majority of swine IAVs do not contain the E627K mutation in the PB2 protein [54]. Instead, swine IAVs possess distinctive adaptive mutations in PB2 (G590S/Q591R), which compensate for the lack of the E627K mutation [53,54,77]. Notably, these swine-origin IAVs containing the alternative mutations caused the 2009 H1N1 pandemic in humans, and the viruses established themselves in humans, becoming one of the seasonal flu strains [58,74,77,78]. Therefore, the adaptive mutations observed in pigs might have interchangeably contributed to viral adaptation in humans.
Zoonotic and reverse-zoonotic events occasionally occur between humans and pigs [79,80,81,82]. Currently, H1N1, H1N2, and H3N2 subtypes of influenza A viruses (IAVs) are globally endemic in pigs [83]. These viruses exhibit high genetic diversity, resulting from diverse hemagglutinin (HA) lineages, neuraminidase (NA), and other gene segments. It is predicted that the bi-directional transmission of IAVs between humans and pigs has contributed to this variability [80,81,82,84]. The 2009 H1N1 pandemic lineage (H1N1/pdm) initially spilled over to pigs, where it underwent genetic and antigenic diversification before reintroducing to humans. Importantly, swine IAVs have evolved distinctly from the human circulating virus, posing challenges to pandemic preparedness [82]. Beyond human-to-pig interfaces, instances of bird-to-pig transmission of IAVs have also been observed sporadically. Various subtypes such as H4N6, H3N2, H9N2, H5N1, H7N9, H10N8, H4N1, H6N6, H4N8, H5N2, and H7N2 have been reported to transmit to pigs [83,85]. Among these, H5N1 and H9N2 avian IAVs have exhibited multiple spillover events from avian species, displaying molecular markers indicative of mammalian adaptation. Therefore, active surveillance of novel IAV introductions in swine populations should be conducted to monitor potential cross-species transmission to humans through pigs.

3.2. Galliformes

Genus Galliformes comprises heavy-bodied, ground-feeding birds often reared by humans for their meat and eggs. They have been closely associated with humans for thousands of years. Due to high-density rearing systems, they are immunologically prone to infectious diseases, increasing the risk of transmission of more virulent pathogens [86]. These pathogens can occasionally cross host-specific barriers, infecting people who are closely associated with them, including veterinarians and farm or slaughterhouse workers [87].
The Galliformes and the Anseriformes (waterfowl) belong to the superorder Galloanserae and have a close genetic relationship. In the context of sialic acid receptors, however, they show a distinctive distribution. While both ducks and chickens express α2,3-SA and α2,6-SA glycans in multiple organs, α2,6-SA glycans are dominant in chicken tracheas, whereas α2,3-SA glycans are most dominant in duck trachea [19,21,88]. Similarly, other Galliformes, such as pheasants, turkeys, quails, and guinea fowls, show both α2,3-SA and α2,6-SA in the respiratory tract [20]. Therefore, they may play a crucial role as “mixing vessels,” facilitating the cross-species transmission of IAVs to humans. Diverse subtypes of avian IAVs have been transmitted from wild waterfowl to gallinaceous birds, and the viruses have adapted to the novel hosts [89,90].
Some H9N2 viruses found in poultry displayed a consistent preference for binding to human-like receptor analogs, in contrast to H9N2 viruses isolated in wild birds [91,92]. Moreover, some H9N2 avian IAVs showed relatively low fusion pH ranging between pH 5.4 and 5.85 [93]. Similarly, Zhong et al. suggest that an essential residue (363K) in HA for aerosol transmission of H9N2 viruses in chickens is responsible for high acid stability [94]. These findings support the potential role of gallinaceous birds as intermediate hosts for the spread of avian IAVs to humans. In contrast, the frequent generation of HA glycosylation during viral adaptation to gallinaceous birds can concomitantly induce stalk truncation of NA to balance HA and NA activity, which may be deleterious for viral transmission in humans [95]. Since there are some conflicting data, in-depth studies are necessary to evaluate the role of gallinaceous birds in the cross-species transmission of IAVs to humans.
IAV transmissions from waterfowl to gallinaceous birds are frequent. H1 to H11 subtypes of avian IAVs (except H13N2 IAV isolated in Turkey in 1990 and 1991) have been reported to circulate in gallinaceous birds, some of which crossed host-specific barriers and were transmitted to humans [87]. Among them, H5 or H7 highly pathogenic avian IAV (HPAI) transmission events to humans are the most noticeable due to their high morbidity and mortality in gallinaceous birds [96,97]. Since the first human infection case in 1997 by H5N1 HPAI, more than 890 cases of HPAI H5N1 human infection have been reported with approximately 50% case fatality proportion [87,96,98,99]. Other HPAIs, including H5N6, H7N7, and H7N9, have also been reported to cause human infection [100,101,102]. According to epidemiological studies, direct exposure to infected gallinaceous birds is thought to be the primary risk factor for these sporadic human infections with HPAI [103]. Low pathogenic avian IAVs, including H3N8, H6N1, H9N2, and H10N8, have also caused spillovers into humans from gallinaceous birds [104,105,106,107]. These spillovers are mostly limited to dead-end infections, but continuous monitoring of poultry-to-human infection of avian IAVs and efforts to break the transmission chain would be important to prevent the emergence of the next pandemic by IAVs.

3.3. Companion Animals

Companion animals are often considered family members and have close physical contact with humans [108]. Although the mutually beneficial relationship can positively impact the mental, physical, and social health of both, the close relationship can increase the risk of cross-species transmission of zoonotic pathogens [109]. Dogs, the first domesticated animals, have shared a profound bond with humans for over 30,000 years. Within the respiratory tract of dogs, both α2,3-SA and α2,6-SA coexist despite the prevalence of α2,3-SA [110]. Dogs exhibit susceptibility to IAV infection, including avian (H3N2, H5N1, H5N2, H6N1, H7N9, H9N2, and H10N8), human (H1N1/pdm and H3N2), and equine (H3N8) origin [6,111,112,113,114,115]. Two distinct canine IAVs (H3N8 and H3N2) have been established in this species, believed to have originated from equine and avian IAVs, respectively [111,116]. While these viral lineages have maintained stability in canine populations without reported zoonotic events, the H3N2 canine IAV has undergone evolutionary adaptations, resulting in enhanced mammalian adaptation, posing an increased risk as a potential zoonotic IAV [109,115,117,118,119,120,121,122]. Canine influenza viruses have acquired mutations that are related to human-like receptor preference, acid stability, and viral polymerase activity, although no well-known adaptive mutations such as E627K or D701N have been observed so far [117]. Moreover, reassortment with H1N1/pdm detected in Korea implies that co-infection of canine IAV with human viruses may lead to a novel virus with pandemic potential [112]. Therefore, cross-species transmission of animal-origin IAVs to dogs might enable the mammalian adaptation of these viruses. This underscores the potential role of dogs in the zoonotic transmission of IAVs, given their intimate association with humans [115].
Cats exhibit the presence of both α2,3-SA and α2,6-SA in their respiratory tract, rendering them susceptible to IAV infection. Various strains of avian (H5N1, H5N6, H7N2, and H9N2), canine (H3N2), and human (H1N1/pdm and H3N2) IAVs have been transmitted to cats [113,123,124,125,126]. While cases are mostly subclinical, some have proven to be lethal. Recently, the clade 2.3.4.4b HPAI has disseminated globally, and it has recurrently spilled over to cats in several countries, resulting in significant disease fatality [127,128,129]. In most cases, the viruses isolated from infected cats acquired mammalian adaptive mutations, such as E627K or D701N in the PB2, without altering their receptor specificity from α2,3-SA to α2,6-SA [125,126,127,129]. However, the potential role of cats as an intermediate host of IAVs warrants thorough investigation.

3.4. Minks

Minks and ferrets belong to the family Mustelidae, and they are genetically close [130]. Similar to ferrets, which have been widely used as animal models for influenza virus studies for several decades, minks are susceptible to several human respiratory viruses, including influenza A virus and SARS-CoV-2 [131]. α2,6-SA is predominantly present in the mink respiratory tract, but α2,3-SA is also found in the mink bronchioles, suggesting potential as an intermediate host for IAV [5,132]. Minks are raised in large groups for their fur; therefore, the consequences of cross-species transmission might be worse than those associated with other wild animals. Genetic analysis of IAVs isolated in minks found that several mammalian adaptive mutations were acquired during adaptation in minks [5]. Notably, according to the analysis using two public influenza databases, minks showed higher α-diversity than other mammalian species, meaning they were infected by more subtypes of IAVs [133]. A serological survey of farmed minks found that they are commonly infected with human H3N2, H1N1/pdm, and avian H7N9, H5N6, and H9N2 IAVs [5,134,135]. Animal experiments showed that minks are susceptible and permissive to human and avian IAVs, and aerosol transmission was stably observed in human IAVs [135]. Since 1984, several subtypes of IAVs have been detected in minks, including H1N1, H1N2, H3N2, H5N1, H5N6, H9N2, and H10N4 [5,132,136,137,138,139]. Of note, clade 2.3.4.4b H5N1, which has spread globally and caused a panzootic, has been found in farmed minks [140]. This virus showed evidence of mink-to-mink transmission and exhibited direct contact and airborne transmission in a ferret study [141]. Collectively, these findings highlight the significant role minks may play in the transmission and evolution of IAV, underscoring the need for stringent surveillance and biosecurity measures in mink farming to prevent potential zoonotic outbreaks.

3.5. Marine Mammals

Different subtypes of IAVs (H1, H3, H4, H5, H7, H10, and H13) have been detected in marine mammals for decades [142,143,144,145,146,147]. The seal pulmonary distribution of α-2,3-SA and α-2,6-SA revealed that α-2,6-SA receptors are widely expressed and α-2,3-SA receptors are also observed, but less frequently [142]. Mammalian adaptive mutations such as D701N in PB2 were found in the H3N8 seal-adapted IAVs in 2011, but similar mutations were not found in other seal-adapted IAVs [142,145]. In ferret studies, the H10N7 virus isolated in seals preferred α-2,6-SA and was aerosol transmissible [146]. Substitutions found in the seal-adapted HA lowered the fusion pH and changed the receptor binding pattern, suggesting that seal infection with avian-origin IAV could lead to zoonotic transmission [146]. Of note, the 2009 pandemic H1N1 viruses were detected twice in northern elephant seals in 2010 and 2019 in California [147,148]. The phylogenetic analysis revealed that these isolated viruses are genetically close to contemporary pdm09 H1N1 viruses circulating in the United States. These events indicate that reverse zoonosis from humans could occur in marine mammals, similar to those in pigs. More recently, several species of marine mammals were found to be infected with clade 2.3.4.4b HPAI in South America, along with the HPAI outbreaks on the continent during 2022–2023 [149]. Sequencing analysis of the viruses isolated from the infected animals found that the virus had already acquired several mammalian adaptive mutations (Q591K and D701N mutations in the PB2 gene). Collectively, these findings indicate that marine mammals are susceptible to both avian and human IAVs, emphasizing the potential role of marine mammals as intermediate hosts in IAV cross-species transmission.

3.6. Other Mammalian Species

Other mammalian species are susceptible to avian IAVs. There have been several spillovers of avian IAVs into zoo animals, including tigers, leopards, and lions [6]. The clade 2.3.4.4b H5N1 viruses have spread along migratory flyways, resulting in genetic reassortment with local low pathogenic avian influenza viruses (LPAIs), leading to an unusually high propensity to infect mammals [150,151]. Notably, independent spillovers of the clade 2.3.4.4b H5N1 virus into red foxes occurred in 2021 and 2022 [152]. The virus isolated from the infected red foxes acquired the E627K mutation in PB2, but no further transmission between foxes was observed.
In March 2024, milk and tissue samples from dairy cattle tested positive for IAV, which was further characterized as the clade 2.3.4.4b H5N1 virus [128]. The virus infection caused mastitis in the infected cows, and evidence of cow-to-cow transmission was found [128]. In addition, domestic cats that consumed raw colostrum and milk from sick cows exhibited a fatal systemic influenza infection [128]. The viruses isolated from the infected cat were phylogenetically related to those isolated from the cows. More importantly, cow-to-human transmissions were confirmed by monitoring people exposed to the infected cows or contaminated materials including cow’s milk [153,154,155]. Phylogenetic analysis revealed that this spillover was the result of a single interspecies transmission event, preceded by genetic reassortment between the clade 2.3.4.4b H5N1 and other LPAIs in wild bird species [150]. This robust genetic reassortment within highly permissive hosts increases genetic diversity and potentially contributes to interspecies transmission [156]. Some mammalian adaptive mutations, including E627K or D701N in PB2, were detected at low frequencies in the bovine H5N1 IAVs [150]. Both α-2,6-SA and α-2,3-SA glycans are expressed in the mammary gland, respiratory tract, and cerebrum of dairy cows, which might explain their susceptibility to IAVs [157]. This suggests a novel route of cross-species transmission of IAVs through the novel animal hosts, dairy cows.

4. Conclusions

Cross-species transmission of viruses from wild or domesticated animals is one of the main sources of emerging infectious agents in humans. Frequent outcomes of cross-species transmission are asymptomatic infection or dead-end events where the virus fails to establish in a new host species. However, rare but critical viral evolution in a new host can cause significant adaptations, leading to widespread outbreaks. From their natural reservoirs in wild waterfowl, IAVs have been transmitted to terrestrial birds and mammals, including humans (Figure 1). Viral adaptation in new hosts or genetic reassortment between human- and animal-origin IAVs in “mixing vessels” can lead to unpredictable changes, increasing zoonotic potential.
Since the 2020s, cross-species transmission of avian-origin IAVs to mammals, including humans, has been increasingly reported. Improved IAV detection and sequencing technologies contribute to this trend, but the risk of stable human-to-human transmission via intermediate hosts remains high. Active surveillance and assessment of zoonotic risks in various animal hosts are crucial for monitoring and preventing the next influenza pandemic.

Funding

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. RS-2023-00210169 and RS-2023-00228644).

Data Availability Statement

Not applicable.

Conflicts of Interest

The author declares no conflicts of interest.

References

  1. Kilbourne, E.D. Influenza pandemics of the 20th century. Emerg. Infect. Dis. 2006, 12, 9–14. [Google Scholar] [CrossRef] [PubMed]
  2. Shapshak, P.; Chiappelli, F.; Somboonwit, C.; Sinnott, J. The Influenza Pandemic of 2009. Mol. Diagn. Ther. 2011, 15, 63–81. [Google Scholar] [CrossRef] [PubMed]
  3. Ozawa, M.; Kawaoka, Y. Cross talk between animal and human influenza viruses. Annu. Rev. Anim. Biosci. 2013, 1, 21–42. [Google Scholar] [CrossRef] [PubMed]
  4. Steel, J.; Lowen, A.C. Influenza A Virus Reassortment. In Influenza Pathogenesis and Control-Volume I; Compans, R.W., Oldstone, M.B.A., Eds.; Springer International Publishing: Cham, Switzerland, 2014; pp. 377–401. [Google Scholar]
  5. Mok, C.K.P.; Qin, K. Mink infection with influenza A viruses: An ignored intermediate host? One Health Adv. 2023, 1, 5. [Google Scholar] [CrossRef] [PubMed]
  6. Abdelwhab, E.M.; Mettenleiter, T.C. Zoonotic Animal Influenza Virus and Potential Mixing Vessel Hosts. Viruses 2023, 15, 980. [Google Scholar] [CrossRef] [PubMed]
  7. Long, J.S.; Mistry, B.; Haslam, S.M.; Barclay, W.S. Host and viral determinants of influenza A virus species specificity. Nat. Rev. Microbiol. 2019, 17, 67–81. [Google Scholar] [CrossRef] [PubMed]
  8. Parrish, C.R.; Murcia, P.R.; Holmes, E.C. Influenza virus reservoirs and intermediate hosts: Dogs, horses, and new possibilities for influenza virus exposure of humans. J. Virol. 2015, 89, 2990–2994. [Google Scholar] [CrossRef] [PubMed]
  9. Andersen, K.G.; Rambaut, A.; Lipkin, W.I.; Holmes, E.C.; Garry, R.F. The proximal origin of SARS-CoV-2. Nat. Med. 2020, 26, 450–452. [Google Scholar] [CrossRef] [PubMed]
  10. Espinosa, R.; Tago, D.; Treich, N. Infectious Diseases and Meat Production. Environ. Resour. Econ. 2020, 76, 1019–1044. [Google Scholar] [CrossRef]
  11. Graham, J.P.; Leibler, J.H.; Price, L.B.; Otte, J.M.; Pfeiffer, D.U.; Tiensin, T.; Silbergeld, E.K. The animal-human interface and infectious disease in industrial food animal production: Rethinking biosecurity and biocontainment. Public Health Rep. 2008, 123, 282–299. [Google Scholar] [CrossRef]
  12. Stel, M.; Eggers, J.; Alonso, W.J. Mitigating Zoonotic Risks in Intensive Farming: Solutions for a Sustainable Change. Ecohealth 2022, 19, 324–328. [Google Scholar] [CrossRef] [PubMed]
  13. Klous, G.; Huss, A.; Heederik, D.J.J.; Coutinho, R.A. Human-livestock contacts and their relationship to transmission of zoonotic pathogens, a systematic review of literature. One Health 2016, 2, 65–76. [Google Scholar] [CrossRef] [PubMed]
  14. Belser, J.A.; Maines, T.R.; Tumpey, T.M.; Katz, J.M. Influenza A virus transmission: Contributing factors and clinical implications. Expert. Rev. Mol. Med. 2010, 12, e39. [Google Scholar] [CrossRef] [PubMed]
  15. Elderfield, R.; Barclay, W. Influenza pandemics. Adv. Exp. Med. Biol. 2011, 719, 81–103. [Google Scholar] [PubMed]
  16. Shinya, K.; Ebina, M.; Yamada, S.; Ono, M.; Kasai, N.; Kawaoka, Y. Avian flu: Influenza virus receptors in the human airway. Nature 2006, 440, 435–436. [Google Scholar] [CrossRef] [PubMed]
  17. Couceiro, J.N.S.S.; Paulson, J.C.; Baum, L.G. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res. 1993, 29, 155–165. [Google Scholar] [CrossRef] [PubMed]
  18. Rogers, G.N.; Paulson, J.C.; Daniels, R.S.; Skehel, J.J.; Wilson, I.A.; Wiley, D.C. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature 1983, 304, 76–78. [Google Scholar] [CrossRef] [PubMed]
  19. Yu, J.E.; Yoon, H.; Lee, H.J.; Lee, J.H.; Chang, B.J.; Song, C.S.; Nahm, S.S. Expression patterns of influenza virus receptors in the respiratory tracts of four species of poultry. J. Vet. Sci. 2011, 12, 7–13. [Google Scholar] [CrossRef] [PubMed]
  20. Kimble, B.; Nieto, G.R.; Perez, D.R. Characterization of influenza virus sialic acid receptors in minor poultry species. Virol. J. 2010, 7, 365. [Google Scholar] [CrossRef]
  21. Kuchipudi, S.V.; Nelli, R.; White, G.A.; Bain, M.; Chang, K.C.; Dunham, S. Differences in influenza virus receptors in chickens and ducks: Implications for interspecies transmission. J. Mol. Genet. Med. 2009, 3, 143–151. [Google Scholar] [CrossRef]
  22. Zhao, C.; Pu, J. Influence of Host Sialic Acid Receptors Structure on the Host Specificity of Influenza Viruses. Viruses 2022, 14, 2141. [Google Scholar] [CrossRef] [PubMed]
  23. Xu, R.; McBride, R.; Nycholat, C.M.; Paulson, J.C.; Wilson, I.A. Structural characterization of the hemagglutinin receptor specificity from the 2009 H1N1 influenza pandemic. J. Virol. 2012, 86, 982–990. [Google Scholar] [CrossRef] [PubMed]
  24. Gamblin, S.J.; Haire, L.F.; Russell, R.J.; Stevens, D.J.; Xiao, B.; Ha, Y.; Vasisht, N.; Steinhauer, D.A.; Daniels, R.S.; Elliot, A.; et al. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 2004, 303, 1838–1842. [Google Scholar] [CrossRef]
  25. Connor, R.J.; Kawaoka, Y.; Webster, R.G.; Paulson, J.C. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 1994, 205, 17–23. [Google Scholar] [CrossRef] [PubMed]
  26. Matrosovich, M.; Tuzikov, A.; Bovin, N.; Gambaryan, A.; Klimov, A.; Castrucci, M.R.; Donatelli, I.; Kawaoka, Y. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J. Virol. 2000, 74, 8502–8512. [Google Scholar] [CrossRef] [PubMed]
  27. Compans, R.W.; Oldstone, M.B.A. Influenza Pathogenesis and Control-Volume I; Springer: Cham, Switzerland, 2014. [Google Scholar]
  28. Mitnaul, L.J.; Matrosovich, M.N.; Castrucci, M.R.; Tuzikov, A.B.; Bovin, N.V.; Kobasa, D.; Kawaoka, Y. Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J. Virol. 2000, 74, 6015–6020. [Google Scholar] [CrossRef] [PubMed]
  29. Xu, R.; Zhu, X.; McBride, R.; Nycholat, C.M.; Yu, W.; Paulson, J.C.; Wilson, I.A. Functional balance of the hemagglutinin and neuraminidase activities accompanies the emergence of the 2009 H1N1 influenza pandemic. J. Virol. 2012, 86, 9221–9232. [Google Scholar] [CrossRef]
  30. Varghese, J.N.; Colman, P.M.; van Donkelaar, A.; Blick, T.J.; Sahasrabudhe, A.; McKimm-Breschkin, J.L. Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases. Proc. Natl. Acad. Sci. USA 1997, 94, 11808–11812. [Google Scholar] [CrossRef] [PubMed]
  31. Hooper, K.A.; Bloom, J.D. A mutant influenza virus that uses an N1 neuraminidase as the receptor-binding protein. J. Virol. 2013, 87, 12531–12540. [Google Scholar] [CrossRef]
  32. Liu, L.; Chen, G.; Huang, S.; Wen, F. Receptor Binding Properties of Neuraminidase for influenza A virus: An Overview of Recent Research Advances. Virulence 2023, 14, 2235459. [Google Scholar] [CrossRef]
  33. Nuss, J.M.; Air, G.M. Transfer of the hemagglutinin activity of influenza virus neuraminidase subtype N9 into an N2 neuraminidase background. Virology 1991, 183, 496–504. [Google Scholar] [CrossRef] [PubMed]
  34. Kobasa, D.; Rodgers, M.E.; Wells, K.; Kawaoka, Y. Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks. J. Virol. 1997, 71, 6706–6713. [Google Scholar] [CrossRef] [PubMed]
  35. Wang, C.C.; Prather, K.A.; Sznitman, J.; Jimenez, J.L.; Lakdawala, S.S.; Tufekci, Z.; Marr, L.C. Airborne transmission of respiratory viruses. Science 2021, 373, eabd9149. [Google Scholar] [CrossRef] [PubMed]
  36. Richard, M.; Fouchier, R.A. Influenza A virus transmission via respiratory aerosols or droplets as it relates to pandemic potential. FEMS Microbiol. Rev. 2016, 40, 68–85. [Google Scholar] [CrossRef] [PubMed]
  37. Russell, C.J. Acid-induced membrane fusion by the hemagglutinin protein and its role in influenza virus biology. Curr. Top. Microbiol. Immunol. 2014, 385, 93–116. [Google Scholar]
  38. Russier, M.; Yang, G.; Rehg, J.E.; Wong, S.S.; Mostafa, H.H.; Fabrizio, T.P.; Barman, S.; Krauss, S.; Webster, R.G.; Webby, R.J.; et al. Molecular requirements for a pandemic influenza virus: An acid-stable hemagglutinin protein. Proc. Natl. Acad. Sci. USA 2016, 113, 1636–1641. [Google Scholar] [CrossRef]
  39. Singanayagam, A.; Zambon, M.; Barclay, W.S. Influenza Virus with Increased pH of Hemagglutinin Activation Has Improved Replication in Cell Culture but at the Cost of Infectivity in Human Airway Epithelium. J. Virol. 2019, 93, e00058-19. [Google Scholar] [CrossRef]
  40. Shelton, H.; Roberts, K.L.; Molesti, E.; Temperton, N.; Barclay, W.S. Mutations in haemagglutinin that affect receptor binding and pH stability increase replication of a PR8 influenza virus with H5 HA in the upper respiratory tract of ferrets and may contribute to transmissibility. J. Gen. Virol. 2013, 94, 1220–1229. [Google Scholar] [CrossRef] [PubMed]
  41. Tosheva, I.I.; Saygan, K.S.; Mijnhardt, S.M.; Russell, C.J.; Fraaij, P.; Herfst, S. Hemagglutinin stability as a key determinant of influenza A virus transmission via air. Curr. Opin. Virol. 2023, 61, 101335. [Google Scholar] [CrossRef]
  42. Imai, M.; Watanabe, T.; Hatta, M.; Das, S.C.; Ozawa, M.; Shinya, K.; Zhong, G.; Hanson, A.; Katsura, H.; Watanabe, S.; et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 2012, 486, 420–428. [Google Scholar] [CrossRef]
  43. Herfst, S.; Schrauwen, E.J.; Linster, M.; Chutinimitkul, S.; de Wit, E.; Munster, V.J.; Sorrell, E.M.; Bestebroer, T.M.; Burke, D.F.; Smith, D.J.; et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 2012, 336, 1534–1541. [Google Scholar] [CrossRef] [PubMed]
  44. Linster, M.; van Boheemen, S.; de Graaf, M.; Schrauwen, E.J.A.; Lexmond, P.; Manz, B.; Bestebroer, T.M.; Baumann, J.; van Riel, D.; Rimmelzwaan, G.F.; et al. Identification, characterization, and natural selection of mutations driving airborne transmission of A/H5N1 virus. Cell 2014, 157, 329–339. [Google Scholar] [CrossRef] [PubMed]
  45. England, R.J.; Homer, J.J.; Knight, L.C.; Ell, S.R. Nasal pH measurement: A reliable and repeatable parameter. Clin. Otolaryngol. Allied Sci. 1999, 24, 67–68. [Google Scholar] [CrossRef] [PubMed]
  46. Galloway, S.E.; Reed, M.L.; Russell, C.J.; Steinhauer, D.A. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: Implications for host range and adaptation. PLoS Pathog. 2013, 9, e1003151. [Google Scholar] [CrossRef] [PubMed]
  47. Yang, G.; Ojha, C.R.; Russell, C.J. Relationship between hemagglutinin stability and influenza virus persistence after exposure to low pH or supraphysiological heating. PLoS Pathog. 2021, 17, e1009910. [Google Scholar] [CrossRef] [PubMed]
  48. Gilbertson, B.; Duncan, M.; Subbarao, K. Role of the viral polymerase during adaptation of influenza A viruses to new hosts. Curr. Opin. Virol. 2023, 62, 101363. [Google Scholar] [CrossRef] [PubMed]
  49. Subbarao, E.K.; London, W.; Murphy, B.R. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J. Virol. 1993, 67, 1761–1764. [Google Scholar] [CrossRef] [PubMed]
  50. Hatta, M.; Gao, P.; Halfmann, P.; Kawaoka, Y. Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses. Science 2001, 293, 1840–1842. [Google Scholar] [CrossRef] [PubMed]
  51. Steel, J.; Lowen, A.C.; Mubareka, S.; Palese, P. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog. 2009, 5, e1000252. [Google Scholar] [CrossRef]
  52. de Jong, M.D.; Simmons, C.P.; Thanh, T.T.; Hien, V.M.; Smith, G.J.; Chau, T.N.; Hoang, D.M.; Chau, N.V.; Khanh, T.H.; Dong, V.C.; et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 2006, 12, 1203–1207. [Google Scholar] [CrossRef]
  53. Yamada, S.; Hatta, M.; Staker, B.L.; Watanabe, S.; Imai, M.; Shinya, K.; Sakai-Tagawa, Y.; Ito, M.; Ozawa, M.; Watanabe, T.; et al. Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog. 2010, 6, e1001034. [Google Scholar] [CrossRef] [PubMed]
  54. Lee, C.Y.; An, S.H.; Choi, J.G.; Lee, Y.J.; Kim, J.H.; Kwon, H.J. Rank orders of mammalian pathogenicity-related PB2 mutations of avian influenza A viruses. Sci. Rep. 2020, 10, 5359. [Google Scholar] [CrossRef] [PubMed]
  55. Lee, C.Y.; An, S.H.; Kim, I.; Go, D.M.; Kim, D.Y.; Choi, J.G.; Lee, Y.J.; Kim, J.H.; Kwon, H.J. Prerequisites for the acquisition of mammalian pathogenicity by influenza A virus with a prototypic avian PB2 gene. Sci. Rep. 2017, 7, 10205. [Google Scholar] [CrossRef] [PubMed]
  56. Zhou, B.; Li, Y.; Halpin, R.; Hine, E.; Spiro, D.J.; Wentworth, D.E. PB2 residue 158 is a pathogenic determinant of pandemic H1N1 and H5 influenza a viruses in mice. J. Virol. 2011, 85, 357–365. [Google Scholar] [CrossRef] [PubMed]
  57. Song, W.; Wang, P.; Mok, B.W.; Lau, S.Y.; Huang, X.; Wu, W.L.; Zheng, M.; Wen, X.; Yang, S.; Chen, Y.; et al. The K526R substitution in viral protein PB2 enhances the effects of E627K on influenza virus replication. Nat. Commun. 2014, 5, 5509. [Google Scholar] [CrossRef] [PubMed]
  58. Mehle, A.; Doudna, J.A. Adaptive strategies of the influenza virus polymerase for replication in humans. Proc. Natl. Acad. Sci. USA 2009, 106, 21312–21316. [Google Scholar] [CrossRef] [PubMed]
  59. Zanin, M.; Wong, S.S.; Barman, S.; Kaewborisuth, C.; Vogel, P.; Rubrum, A.; Darnell, D.; Marinova-Petkova, A.; Krauss, S.; Webby, R.J.; et al. Molecular basis of mammalian transmissibility of avian H1N1 influenza viruses and their pandemic potential. Proc. Natl. Acad. Sci. USA 2017, 114, 11217–11222. [Google Scholar] [CrossRef]
  60. Noronha, J.M.; Liu, M.; Squires, R.B.; Pickett, B.E.; Hale, B.G.; Air, G.M.; Galloway, S.E.; Takimoto, T.; Schmolke, M.; Hunt, V.; et al. Influenza virus sequence feature variant type analysis: Evidence of a role for NS1 in influenza virus host range restriction. J. Virol. 2012, 86, 5857–5866. [Google Scholar] [CrossRef] [PubMed]
  61. Obenauer, J.C.; Denson, J.; Mehta, P.K.; Su, X.; Mukatira, S.; Finkelstein, D.B.; Xu, X.; Wang, J.; Ma, J.; Fan, Y.; et al. Large-scale sequence analysis of avian influenza isolates. Science 2006, 311, 1576–1580. [Google Scholar] [CrossRef]
  62. Jackson, D.; Hossain, M.J.; Hickman, D.; Perez, D.R.; Lamb, R.A. A new influenza virus virulence determinant: The NS1 protein four C-terminal residues modulate pathogenicity. Proc. Natl. Acad. Sci. USA 2008, 105, 4381–4386. [Google Scholar] [CrossRef]
  63. Long, J.S.; Giotis, E.S.; Moncorge, O.; Frise, R.; Mistry, B.; James, J.; Morisson, M.; Iqbal, M.; Vignal, A.; Skinner, M.A.; et al. Species difference in ANP32A underlies influenza A virus polymerase host restriction. Nature 2016, 529, 101–104. [Google Scholar] [CrossRef] [PubMed]
  64. Carrique, L.; Fan, H.; Walker, A.P.; Keown, J.R.; Sharps, J.; Staller, E.; Barclay, W.S.; Fodor, E.; Grimes, J.M. Host ANP32A mediates the assembly of the influenza virus replicase. Nature 2020, 587, 638–643. [Google Scholar] [CrossRef] [PubMed]
  65. Sugiyama, K.; Kawaguchi, A.; Okuwaki, M.; Nagata, K. pp32 and APRIL are host cell-derived regulators of influenza virus RNA synthesis from cRNA. Elife 2015, 4, e08939. [Google Scholar] [CrossRef] [PubMed]
  66. Weber, M.; Sediri, H.; Felgenhauer, U.; Binzen, I.; Banfer, S.; Jacob, R.; Brunotte, L.; Garcia-Sastre, A.; Schmid-Burgk, J.L.; Schmidt, T.; et al. Influenza virus adaptation PB2-627K modulates nucleocapsid inhibition by the pathogen sensor RIG-I. Cell Host Microbe 2015, 17, 309–319. [Google Scholar] [CrossRef] [PubMed]
  67. Riegger, D.; Hai, R.; Dornfeld, D.; Manz, B.; Leyva-Grado, V.; Sanchez-Aparicio, M.T.; Albrecht, R.A.; Palese, P.; Haller, O.; Schwemmle, M.; et al. The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA. J. Virol. 2015, 89, 2241–2252. [Google Scholar] [CrossRef] [PubMed]
  68. Manz, B.; Dornfeld, D.; Gotz, V.; Zell, R.; Zimmermann, P.; Haller, O.; Kochs, G.; Schwemmle, M. Pandemic influenza A viruses escape from restriction by human MxA through adaptive mutations in the nucleoprotein. PLoS Pathog. 2013, 9, e1003279. [Google Scholar] [CrossRef]
  69. Ma, W.; Kahn, R.E.; Richt, J.A. The pig as a mixing vessel for influenza viruses: Human and veterinary implications. J. Mol. Genet. Med. 2008, 3, 158–166. [Google Scholar] [CrossRef] [PubMed]
  70. Nelli, R.K.; Kuchipudi, S.V.; White, G.A.; Perez, B.B.; Dunham, S.P.; Chang, K.-C. Comparative distribution of human and avian type sialic acid influenza receptors in the pig. BMC Vet. Res. 2010, 6, 4. [Google Scholar] [CrossRef] [PubMed]
  71. Trebbien, R.; Larsen, L.E.; Viuff, B.M. Distribution of sialic acid receptors and influenza A virus of avian and swine origin in experimentally infected pigs. Virol. J. 2011, 8, 434. [Google Scholar] [CrossRef]
  72. Smith, G.J.; Vijaykrishna, D.; Bahl, J.; Lycett, S.J.; Worobey, M.; Pybus, O.G.; Ma, S.K.; Cheung, C.L.; Raghwani, J.; Bhatt, S.; et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009, 459, 1122–1125. [Google Scholar] [CrossRef]
  73. Fraser, C.; Donnelly, C.A.; Cauchemez, S.; Hanage, W.P.; Van Kerkhove, M.D.; Hollingsworth, T.D.; Griffin, J.; Baggaley, R.F.; Jenkins, H.E.; Lyons, E.J.; et al. Pandemic potential of a strain of influenza A (H1N1): Early findings. Science 2009, 324, 1557–1561. [Google Scholar] [CrossRef] [PubMed]
  74. Su, Y.C.F.; Bahl, J.; Joseph, U.; Butt, K.M.; Peck, H.A.; Koay, E.S.C.; Oon, L.L.E.; Barr, I.G.; Vijaykrishna, D.; Smith, G.J.D. Phylodynamics of H1N1/2009 influenza reveals the transition from host adaptation to immune-driven selection. Nat. Commun. 2015, 6, 7952. [Google Scholar] [CrossRef] [PubMed]
  75. Strengell, M.; Ikonen, N.; Ziegler, T.; Julkunen, I. Minor changes in the hemagglutinin of influenza A(H1N1)2009 virus alter its antigenic properties. PLoS ONE 2011, 6, e25848. [Google Scholar] [CrossRef] [PubMed]
  76. Hu, M.; Yang, G.; DeBeauchamp, J.; Crumpton, J.C.; Kim, H.; Li, L.; Wan, X.F.; Kercher, L.; Bowman, A.S.; Webster, R.G.; et al. HA stabilization promotes replication and transmission of swine H1N1 gamma influenza viruses in ferrets. Elife 2020, 9, e56236. [Google Scholar] [CrossRef] [PubMed]
  77. Liu, Q.; Qiao, C.; Marjuki, H.; Bawa, B.; Ma, J.; Guillossou, S.; Webby, R.J.; Richt, J.A.; Ma, W. Combination of PB2 271A and SR polymorphism at positions 590/591 is critical for viral replication and virulence of swine influenza virus in cultured cells and in vivo. J. Virol. 2012, 86, 1233–1237. [Google Scholar] [CrossRef] [PubMed]
  78. Zehender, G.; Pariani, E.; Piralla, A.; Lai, A.; Gabanelli, E.; Ranghiero, A.; Ebranati, E.; Amendola, A.; Campanini, G.; Rovida, F.; et al. Reconstruction of the evolutionary dynamics of the A(H1N1)pdm09 influenza virus in Italy during the pandemic and post-pandemic phases. PLoS ONE 2012, 7, e47517. [Google Scholar] [CrossRef] [PubMed]
  79. Cheung, J.; Bui, A.N.; Younas, S.; Edwards, K.M.; Nguyen, H.Q.; Pham, N.T.; Bui, V.N.; Peiris, M.; Dhanasekaran, V. Long-Term Epidemiology and Evolution of Swine Influenza Viruses, Vietnam. Emerg. Infect. Dis. 2023, 29, 1397–1406. [Google Scholar] [CrossRef] [PubMed]
  80. Markin, A.; Ciacci Zanella, G.; Arendsee, Z.W.; Zhang, J.; Krueger, K.M.; Gauger, P.C.; Vincent Baker, A.L.; Anderson, T.K. Reverse-zoonoses of 2009 H1N1 pandemic influenza A viruses and evolution in United States swine results in viruses with zoonotic potential. PLoS Pathog. 2023, 19, e1011476. [Google Scholar] [CrossRef] [PubMed]
  81. Nelson, M.I.; Vincent, A.L. Reverse zoonosis of influenza to swine: New perspectives on the human-animal interface. Trends Microbiol. 2015, 23, 142–153. [Google Scholar] [CrossRef]
  82. Cook, P.W.; Stark, T.; Jones, J.; Kondor, R.; Zanders, N.; Benfer, J.; Scott, S.; Jang, Y.; Janas-Martindale, A.; Lindstrom, S.; et al. Detection and Characterization of Swine Origin Influenza A(H1N1) Pandemic 2009 Viruses in Humans following Zoonotic Transmission. J. Virol. 2020, 95, 10–1128. [Google Scholar] [CrossRef]
  83. Chauhan, R.P.; Gordon, M.L. A Systematic Review Analyzing the Prevalence and Circulation of Influenza Viruses in Swine Population Worldwide. Pathogens 2020, 9, 355. [Google Scholar] [CrossRef] [PubMed]
  84. Anderson, T.K.; Chang, J.; Arendsee, Z.W.; Venkatesh, D.; Souza, C.K.; Kimble, J.B.; Lewis, N.S.; Davis, C.T.; Vincent, A.L. Swine Influenza A Viruses and the Tangled Relationship with Humans. Cold Spring Harb. Perspect. Med. 2021, 11, a038737. [Google Scholar] [CrossRef]
  85. Chauhan, R.P.; Gordon, M.L. Deciphering transmission dynamics and spillover of avian influenza viruses from avian species to swine populations globally. Virus Genes 2021, 57, 541–555. [Google Scholar] [CrossRef] [PubMed]
  86. Gilbert, M.; Xiao, X.; Robinson, T.P. Intensifying poultry production systems and the emergence of avian influenza in China: A ‘One Health/Ecohealth’ epitome. Arch. Public. Health 2017, 75, 48. [Google Scholar] [CrossRef] [PubMed]
  87. Quan, C.; Wang, Q.; Zhang, J.; Zhao, M.; Dai, Q.; Huang, T.; Zhang, Z.; Mao, S.; Nie, Y.; Liu, J.; et al. Avian Influenza A Viruses among Occupationally Exposed Populations, China, 2014–2016. Emerg. Infect. Dis. 2019, 25, 2215–2225. [Google Scholar] [CrossRef]
  88. Gambaryan, A.S.; Tuzikov, A.B.; Bovin, N.V.; Yamnikova, S.S.; Lvov, D.K.; Webster, R.G.; Matrosovich, M.N. Differences between influenza virus receptors on target cells of duck and chicken and receptor specificity of the 1997 H5N1 chicken and human influenza viruses from Hong Kong. Avian Dis. 2003, 47 (Suppl. S3), 1154–1160. [Google Scholar] [CrossRef]
  89. Pillai, S.P.; Pantin-Jackwood, M.; Yassine, H.M.; Saif, Y.M.; Lee, C.W. The high susceptibility of turkeys to influenza viruses of different origins implies their importance as potential intermediate hosts. Avian Dis. 2010, 54 (Suppl. S1), 522–526. [Google Scholar] [CrossRef] [PubMed]
  90. Abdelwhab, E.S.M.; Veits, J.; Mettenleiter, T.C. Genetic changes that accompanied shifts of low pathogenic avian influenza viruses toward higher pathogenicity in poultry. Virulence 2013, 4, 441–452. [Google Scholar] [CrossRef]
  91. Matrosovich, M.N.; Krauss, S.; Webster, R.G. H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity. Virology 2001, 281, 156–162. [Google Scholar] [CrossRef]
  92. Guo, J.; Wang, Y.; Zhao, C.; Gao, X.; Zhang, Y.; Li, J.; Wang, M.; Zhang, H.; Liu, W.; Wang, C.; et al. Molecular characterization, receptor binding property, and replication in chickens and mice of H9N2 avian influenza viruses isolated from chickens, peafowls, and wild birds in eastern China. Emerg. Microbes Infect. 2021, 10, 2098–2112. [Google Scholar] [CrossRef]
  93. Peacock, T.P.; Benton, D.J.; Sadeyen, J.R.; Chang, P.; Sealy, J.E.; Bryant, J.E.; Martin, S.R.; Shelton, H.; McCauley, J.W.; Barclay, W.S.; et al. Variability in H9N2 haemagglutinin receptor-binding preference and the pH of fusion. Emerg. Microbes Infect. 2017, 6, e11. [Google Scholar] [CrossRef] [PubMed]
  94. Zhong, L.; Wang, X.; Li, Q.; Liu, D.; Chen, H.; Zhao, M.; Gu, X.; He, L.; Liu, X.; Gu, M.; et al. Molecular mechanism of the airborne transmissibility of H9N2 avian influenza A viruses in chickens. J. Virol. 2014, 88, 9568–9578. [Google Scholar] [CrossRef] [PubMed]
  95. Long, J.S.; Benfield, C.T.; Barclay, W.S. One-way trip: Influenza virus’ adaptation to gallinaceous poultry may limit its pandemic potential. Bioessays 2015, 37, 204–212. [Google Scholar] [CrossRef] [PubMed]
  96. Poovorawan, Y.; Pyungporn, S.; Prachayangprecha, S.; Makkoch, J. Global alert to avian influenza virus infection: From H5N1 to H7N9. Pathog. Glob. Health 2013, 107, 217–223. [Google Scholar] [CrossRef] [PubMed]
  97. Tian, H.; Zhou, S.; Dong, L.; Van Boeckel, T.P.; Cui, Y.; Newman, S.H.; Takekawa, J.Y.; Prosser, D.J.; Xiao, X.; Wu, Y.; et al. Avian influenza H5N1 viral and bird migration networks in Asia. Proc. Natl. Acad. Sci. USA 2015, 112, 172–177. [Google Scholar] [CrossRef] [PubMed]
  98. Charostad, J.; Rezaei Zadeh Rukerd, M.; Mahmoudvand, S.; Bashash, D.; Hashemi, S.M.A.; Nakhaie, M.; Zandi, K. A comprehensive review of highly pathogenic avian influenza (HPAI) H5N1: An imminent threat at doorstep. Travel Med. Infect. Dis. 2023, 55, 102638. [Google Scholar] [CrossRef] [PubMed]
  99. Yang, L.; Xie, J.; Zhang, Y.; Zhu, W.; Li, X.; Wei, H.; Li, Z.; Zhao, L.; Bo, H.; Liu, J.; et al. Emergence of waterfowl-originated gene cassettes in HPAI H7N9 viruses caused severe human infection in Fujian, China. Influenza Other Respir. Viruses 2019, 13, 496–503. [Google Scholar] [CrossRef]
  100. Pan, M.; Gao, R.; Lv, Q.; Huang, S.; Zhou, Z.; Yang, L.; Li, X.; Zhao, X.; Zou, X.; Tong, W.; et al. Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: Virological and clinical findings. J. Infect. 2016, 72, 52–59. [Google Scholar] [CrossRef]
  101. Li, Q.; Zhou, L.; Zhou, M.; Chen, Z.; Li, F.; Wu, H.; Xiang, N.; Chen, E.; Tang, F.; Wang, D.; et al. Epidemiology of human infections with avian influenza A(H7N9) virus in China. N. Engl. J. Med. 2014, 370, 520–532. [Google Scholar] [CrossRef]
  102. Fouchier, R.A.M.; Schneeberger, P.M.; Rozendaal, F.W.; Broekman, J.M.; Kemink, S.A.G.; Munster, V.; Kuiken, T.; Rimmelzwaan, G.F.; Schutten, M.; van Doornum, G.J.J.; et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc. Natl. Acad. Sci. USA 2004, 101, 1356–1361. [Google Scholar] [CrossRef]
  103. Swayne, D.E. Occupational and consumer risks from avian influenza viruses. Dev. Biol. 2006, 124, 85–90. [Google Scholar]
  104. Wei, S.H.; Yang, J.R.; Wu, H.S.; Chang, M.C.; Lin, J.S.; Lin, C.Y.; Liu, Y.L.; Lo, Y.C.; Yang, C.H.; Chuang, J.H.; et al. Human infection with avian influenza A H6N1 virus: An epidemiological analysis. Lancet Respir. Med. 2013, 1, 771–778. [Google Scholar] [CrossRef] [PubMed]
  105. Bao, P.; Liu, Y.; Zhang, X.; Fan, H.; Zhao, J.; Mu, M.; Li, H.; Wang, Y.; Ge, H.; Li, S.; et al. Human infection with a reassortment avian influenza A H3N8 virus: An epidemiological investigation study. Nat. Commun. 2022, 13, 6817. [Google Scholar] [CrossRef] [PubMed]
  106. Butt, K.M.; Smith Gavin, J.D.; Chen, H.; Zhang, L.J.; Leung, Y.H.C.; Xu, K.M.; Lim, W.; Webster Robert, G.; Yuen, K.Y.; Peiris, J.S.M.; et al. Human Infection with an Avian H9N2 Influenza A Virus in Hong Kong in 2003. J. Clin. Microbiol. 2005, 43, 5760–5767. [Google Scholar] [CrossRef] [PubMed]
  107. To, K.K.; Tsang, A.K.; Chan, J.F.; Cheng, V.C.; Chen, H.; Yuen, K.Y. Emergence in China of human disease due to avian influenza A(H10N8)—Cause for concern? J. Infect. 2014, 68, 205–215. [Google Scholar] [CrossRef] [PubMed]
  108. Amiot, C.; Bastian, B.; Martens, P. People and Companion Animals: It Takes Two to Tango. BioScience 2016, 66, 552–560. [Google Scholar] [CrossRef]
  109. Overgaauw, P.A.M.; Vinke, C.M.; Hagen, M.; Lipman, L.J.A. A One Health Perspective on the Human-Companion Animal Relationship with Emphasis on Zoonotic Aspects. Int. J. Environ. Res. Public Health 2020, 17, 3789. [Google Scholar] [CrossRef] [PubMed]
  110. Ning, Z.Y.; Wu, X.T.; Cheng, Y.F.; Qi, W.B.; An, Y.F.; Wang, H.; Zhang, G.H.; Li, S.J. Tissue distribution of sialic acid-linked influenza virus receptors in beagle dogs. J. Vet. Sci. 2012, 13, 219–222. [Google Scholar] [CrossRef] [PubMed]
  111. Daly, J.M.; Blunden, A.S.; Macrae, S.; Miller, J.; Bowman, S.J.; Kolodziejek, J.; Nowotny, N.; Smith, K.C. Transmission of equine influenza virus to English foxhounds. Emerg. Infect. Dis. 2008, 14, 461–464. [Google Scholar] [CrossRef]
  112. Song, D.; Moon, H.J.; An, D.J.; Jeoung, H.Y.; Kim, H.; Yeom, M.J.; Hong, M.; Nam, J.H.; Park, S.J.; Park, B.K.; et al. A novel reassortant canine H3N1 influenza virus between pandemic H1N1 and canine H3N2 influenza viruses in Korea. J. Gen. Virol. 2012, 93, 551–554. [Google Scholar] [CrossRef]
  113. Wasik, B.R.; Voorhees, I.E.H.; Parrish, C.R. Canine and Feline Influenza. Cold Spring Harb. Perspect. Med. 2021, 11, a038562. [Google Scholar] [CrossRef] [PubMed]
  114. Lin, H.T.; Wang, C.H.; Chueh, L.L.; Su, B.L.; Wang, L.C. Influenza A(H6N1) Virus in Dogs, Taiwan. Emerg. Infect. Dis. 2015, 21, 2154–2157. [Google Scholar] [CrossRef] [PubMed]
  115. Zhu, H.; Hughes, J.; Murcia, P.R. Origins and Evolutionary Dynamics of H3N2 Canine Influenza Virus. J. Virol. 2015, 89, 5406–5418. [Google Scholar] [CrossRef] [PubMed]
  116. Song, D.; Kang, B.; Lee, C.; Jung, K.; Ha, G.; Kang, D.; Park, S.; Park, B.; Oh, J. Transmission of avian influenza virus (H3N2) to dogs. Emerg. Infect. Dis. 2008, 14, 741–746. [Google Scholar] [CrossRef] [PubMed]
  117. Chen, M.; Lyu, Y.; Wu, F.; Zhang, Y.; Li, H.; Wang, R.; Liu, Y.; Yang, X.; Zhou, L.; Zhang, M.; et al. Increased public health threat of avian-origin H3N2 influenza virus caused by its evolution in dogs. Elife 2023, 12, e83470. [Google Scholar] [CrossRef] [PubMed]
  118. Lee, C.Y. Evolution and international transmission of H3N2 canine influenza A viruses from Korea during 2014–2017. J. Vet. Sci. 2023, 24, e78. [Google Scholar] [CrossRef] [PubMed]
  119. Guo, F.; Roy, A.; Wang, R.; Yang, J.; Zhang, Z.; Luo, W.; Shen, X.; Chen, R.A.; Irwin, D.M.; Shen, Y. Host Adaptive Evolution of Avian-Origin H3N2 Canine Influenza Virus. Front. Microbiol. 2021, 12, 655228. [Google Scholar] [CrossRef] [PubMed]
  120. Yang, G.; Li, S.; Blackmon, S.; Ye, J.; Bradley, K.C.; Cooley, J.; Smith, D.; Hanson, L.; Cardona, C.; Steinhauer, D.A.; et al. Mutation tryptophan to leucine at position 222 of haemagglutinin could facilitate H3N2 influenza A virus infection in dogs. J. Gen. Virol. 2013, 94, 2599–2608. [Google Scholar] [CrossRef]
  121. Wu, M.; Su, R.; Gu, Y.; Yu, Y.; Li, S.; Sun, H.; Pan, L.; Cui, X.; Zhu, X.; Yang, Q.; et al. Molecular Characteristics, Antigenicity, Pathogenicity, and Zoonotic Potential of a H3N2 Canine Influenza Virus Currently Circulating in South China. Front. Microbiol. 2021, 12, 628979. [Google Scholar] [CrossRef]
  122. Lin, Y.; Xie, X.; Zhao, Y.; Kalhoro, D.H.; Lu, C.; Liu, Y. Enhanced replication of avian-origin H3N2 canine influenza virus in eggs, cell cultures and mice by a two-amino acid insertion in neuraminidase stalk. Vet. Res. 2016, 47, 53. [Google Scholar] [CrossRef]
  123. Jeoung, H.Y.; Lim, S.I.; Shin, B.H.; Lim, J.A.; Song, J.Y.; Song, D.S.; Kang, B.K.; Moon, H.J.; An, D.J. A novel canine influenza H3N2 virus isolated from cats in an animal shelter. Vet. Microbiol. 2013, 165, 281–286. [Google Scholar] [CrossRef] [PubMed]
  124. Rimmelzwaan, G.F.; van Riel, D.; Baars, M.; Bestebroer, T.M.; van Amerongen, G.; Fouchier, R.A.; Osterhaus, A.D.; Kuiken, T. Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am. J. Pathol. 2006, 168, 176–183; quiz 364. [Google Scholar] [CrossRef] [PubMed]
  125. Hatta, M.; Zhong, G.; Gao, Y.; Nakajima, N.; Fan, S.; Chiba, S.; Deering, K.M.; Ito, M.; Imai, M.; Kiso, M.; et al. Characterization of a Feline Influenza A(H7N2) Virus. Emerg. Infect. Dis. 2018, 24, 75–86. [Google Scholar] [CrossRef] [PubMed]
  126. Songserm, T.; Amonsin, A.; Jam-on, R.; Sae-Heng, N.; Meemak, N.; Pariyothorn, N.; Payungporn, S.; Theamboonlers, A.; Poovorawan, Y. Avian influenza H5N1 in naturally infected domestic cat. Emerg. Infect. Dis. 2006, 12, 681–683. [Google Scholar] [CrossRef] [PubMed]
  127. Rabalski, L.; Milewska, A.; Pohlmann, A.; Gackowska, K.; Lepionka, T.; Szczepaniak, K.; Swiatalska, A.; Sieminska, I.; Arent, Z.; Beer, M.; et al. Emergence and potential transmission route of avian influenza A (H5N1) virus in domestic cats in Poland, June 2023. Eurosurveillance 2023, 28, 2300390. [Google Scholar] [CrossRef] [PubMed]
  128. Burrough, E.; Magstadt, D.; Petersen, B.; Timmermans, S.; Gauger, P.; Zhang, J.; Siepker, C.; Mainenti, M.; Li, G.; Thompson, A.; et al. Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b Virus Infection in Domestic Dairy Cattle and Cats, United States, 2024. Emerg. Infect. Dis. J. 2024, 30, 1335–1343. [Google Scholar] [CrossRef] [PubMed]
  129. Lee, K.; Yeom, M.; Vu, T.T.H.; Do, H.Q.; Na, W.; Lee, M.; Jeong, D.G.; Cheon, D.S.; Song, D. Characterization of highly pathogenic avian influenza A (H5N1) viruses isolated from cats in South Korea, 2023. Emerg. Microbes Infect. 2024, 13, 2290835. [Google Scholar] [CrossRef] [PubMed]
  130. Kurose, N.; Abramov, A.V.; Masuda, R. Molecular phylogeny and taxonomy of the genus Mustela (Mustelidae, Carnivora), inferred from mitochondrial DNA sequences: New perspectives on phylogenetic status of the back-striped weasel and American mink. Mammal Study 2008, 33, 25–33. [Google Scholar] [CrossRef]
  131. Bouvier, N.M.; Lowen, A.C. Animal Models for Influenza Virus Pathogenesis and Transmission. Viruses 2010, 2, 1530–1563. [Google Scholar] [CrossRef]
  132. Peng, L.; Chen, C.; Kai-yi, H.; Feng-xia, Z.; Yan-li, Z.; Zong-shuai, L.; Xing-xiao, Z.; Shi-jin, J.; Zhi-jing, X. Molecular characterization of H9N2 influenza virus isolated from mink and its pathogenesis in mink. Vet. Microbiol. 2015, 176, 88–96. [Google Scholar] [CrossRef]
  133. Zhao, P.; Sun, L.; Xiong, J.; Wang, C.; Chen, L.; Yang, P.; Yu, H.; Yan, Q.; Cheng, Y.; Jiang, L.; et al. Semiaquatic mammals might be intermediate hosts to spread avian influenza viruses from avian to human. Sci. Rep. 2019, 9, 11641. [Google Scholar] [CrossRef] [PubMed]
  134. Zhang, C.; Xuan, Y.; Shan, H.; Yang, H.; Wang, J.; Wang, K.; Li, G.; Qiao, J. Avian influenza virus H9N2 infections in farmed minks. Virol. J. 2015, 12, 180. [Google Scholar] [CrossRef] [PubMed]
  135. Sun, H.; Li, F.; Liu, Q.; Du, J.; Liu, L.; Sun, H.; Li, C.; Liu, J.; Zhang, X.; Yang, J.; et al. Mink is a highly susceptible host species to circulating human and avian influenza viruses. Emerg. Microbes Infect. 2021, 10, 472–480. [Google Scholar] [CrossRef] [PubMed]
  136. Jiang, W.; Wang, S.; Zhang, C.; Li, J.; Hou, G.; Peng, C.; Chen, J.; Shan, H. Characterization of H5N1 highly pathogenic mink influenza viruses in eastern China. Vet. Microbiol. 2017, 201, 225–230. [Google Scholar] [CrossRef] [PubMed]
  137. Klingeborn, B.; Englund, L.; Rott, R.; Juntti, N.; Rockborn, G. An avian influenza A virus killing a mammalian species—The mink. Brief report. Arch. Virol. 1985, 86, 347–351. [Google Scholar] [CrossRef] [PubMed]
  138. Yoon, K.J.; Schwartz, K.; Sun, D.; Zhang, J.; Hildebrandt, H. Naturally occurring Influenza A virus subtype H1N2 infection in a Midwest United States mink (Mustela vison) ranch. J. Vet. Diagn. Investig. 2012, 24, 388–391. [Google Scholar] [CrossRef] [PubMed]
  139. Gagnon, C.A.; Spearman, G.; Hamel, A.; Godson, D.L.; Fortin, A.; Fontaine, G.; Tremblay, D. Characterization of a Canadian mink H3N2 influenza A virus isolate genetically related to triple reassortant swine influenza virus. J. Clin. Microbiol. 2009, 47, 796–799. [Google Scholar] [CrossRef] [PubMed]
  140. Aguero, M.; Monne, I.; Sanchez, A.; Zecchin, B.; Fusaro, A.; Ruano, M.J.; Del Valle Arrojo, M.; Fernandez-Antonio, R.; Souto, A.M.; Tordable, P.; et al. Highly pathogenic avian influenza A(H5N1) virus infection in farmed minks, Spain, October 2022. Eurosurveillance 2023, 28, 2300001. [Google Scholar] [CrossRef] [PubMed]
  141. Restori, K.H.; Septer, K.M.; Field, C.J.; Patel, D.R.; VanInsberghe, D.; Raghunathan, V.; Lowen, A.C.; Sutton, T.C. Risk assessment of a highly pathogenic H5N1 influenza virus from mink. Nat. Commun. 2024, 15, 4112. [Google Scholar] [CrossRef]
  142. Anthony, S.J.; St Leger, J.A.; Pugliares, K.; Ip, H.S.; Chan, J.M.; Carpenter, Z.W.; Navarrete-Macias, I.; Sanchez-Leon, M.; Saliki, J.T.; Pedersen, J.; et al. Emergence of fatal avian influenza in New England harbor seals. mBio 2012, 3, e00166-12. [Google Scholar] [CrossRef]
  143. Hinshaw, V.S.; Bean, W.J.; Webster, R.G.; Rehg, J.E.; Fiorelli, P.; Early, G.; Geraci, J.R.; St Aubin, D.J. Are seals frequently infected with avian influenza viruses? J. Virol. 1984, 51, 863–865. [Google Scholar] [CrossRef] [PubMed]
  144. Callan, R.J.; Early, G.; Kida, H.; Hinshaw, V.S. The appearance of H3 influenza viruses in seals. J. Gen. Virol. 1995, 76, 199–203. [Google Scholar] [CrossRef] [PubMed]
  145. Runstadler, J.A.; Puryear, W. A Brief Introduction to Influenza A Virus in Marine Mammals. Methods Mol. Biol. 2020, 2123, 429–450. [Google Scholar] [PubMed]
  146. Herfst, S.; Zhang, J.; Richard, M.; McBride, R.; Lexmond, P.; Bestebroer, T.M.; Spronken, M.I.J.; de Meulder, D.; van den Brand, J.M.; Rosu, M.E.; et al. Hemagglutinin Traits Determine Transmission of Avian A/H10N7 Influenza Virus between Mammals. Cell Host Microbe 2020, 28, 602–613.e7. [Google Scholar] [CrossRef] [PubMed]
  147. Plancarte, M.; Kovalenko, G.; Baldassano, J.; Ramirez, A.L.; Carrillo, S.; Duignan, P.J.; Goodfellow, I.; Bortz, E.; Dutta, J.; van Bakel, H.; et al. Human influenza A virus H1N1 in marine mammals in California, 2019. PLoS ONE 2023, 18, e0283049. [Google Scholar] [CrossRef] [PubMed]
  148. Goldstein, T.; Mena, I.; Anthony, S.J.; Medina, R.; Robinson, P.W.; Greig, D.J.; Costa, D.P.; Lipkin, W.I.; Garcia-Sastre, A.; Boyce, W.M. Pandemic H1N1 influenza isolated from free-ranging Northern Elephant Seals in 2010 off the central California coast. PLoS ONE 2013, 8, e62259. [Google Scholar] [CrossRef] [PubMed]
  149. Rimondi, A.; Vanstreels, R.E.T.; Olivera, V.; Donini, A.; Lauriente, M.M.; Uhart, M.M. Highly Pathogenic Avian Influenza A(H5N1) Viruses from Multispecies Outbreak, Argentina, August 2023. Emerg. Infect. Dis. 2024, 30, 812–814. [Google Scholar] [CrossRef] [PubMed]
  150. Nguyen, T.-Q.; Hutter, C.; Markin, A.; Thomas, M.; Lantz, K.; Killian, M.L.; Janzen, G.M.; Vijendran, S.; Wagle, S.; Inderski, B.; et al. Emergence and interstate spread of highly pathogenic avian influenza A(H5N1) in dairy cattle. bioRxiv 2024. preprint. [Google Scholar]
  151. Fusaro, A.; Zecchin, B.; Giussani, E.; Palumbo, E.; Aguero-Garcia, M.; Bachofen, C.; Balint, A.; Banihashem, F.; Banyard, A.C.; Beerens, N.; et al. High pathogenic avian influenza A(H5) viruses of clade 2.3.4.4b in Europe-Why trends of virus evolution are more difficult to predict. Virus Evol. 2024, 10, veae027. [Google Scholar] [CrossRef]
  152. Bordes, L.; Vreman, S.; Heutink, R.; Roose, M.; Venema, S.; Pritz-Verschuren Sylvia, B.E.; Rijks Jolianne, M.; Gonzales José, L.; Germeraad Evelien, A.; Engelsma, M.; et al. Highly Pathogenic Avian Influenza H5N1 Virus Infections in Wild Red Foxes (Vulpes vulpes) Show Neurotropism and Adaptive Virus Mutations. Microbiol. Spectr. 2023, 11, e02867-22. [Google Scholar] [CrossRef]
  153. Abbasi, J. As a Third Worker Tests Positive for Bird Flu in US Dairy Cattle Outbreak, Here’s What to Know. JAMA 2024. preprint. [Google Scholar] [CrossRef] [PubMed]
  154. Garg, S. Outbreak of highly pathogenic avian influenza A (H5N1) viruses in US dairy cattle and detection of two human cases—United States, 2024. MMWR Morb. Mortal. Wkly. Rep. 2024, 73, 501–505. [Google Scholar] [CrossRef] [PubMed]
  155. Abdelwhab, E.M.; Beer, M. Panzootic HPAIV H5 and risks to novel mammalian hosts. NPJ Viruses 2024, 2, 22. [Google Scholar] [CrossRef]
  156. Ganti, K.; Bagga, A.; DaSilva, J.; Shepard, S.S.; Barnes, J.R.; Shriner, S.; Koelle, K.; Lowen, A.C. Avian Influenza A Viruses Reassort and Diversify Differently in Mallards and Mammals. Viruses 2021, 13, 509. [Google Scholar] [CrossRef]
  157. Kristensen, C.; Jensen, H.E.; Trebbien, R.; Webby, R.J.; Larsen, L.E. The avian and human influenza A virus receptors sialic acid (SA)-α2,3 and SA-α2,6 are widely expressed in the bovine mammary gland. bioRxiv 2024. preprint. [Google Scholar]
Figure 1. Cross-species transmission of influenza A virus. From their natural reservoirs in wild waterfowl, influenza A viruses (IAVs) have been transmitted to various animal species. The majority of these cross-species transmission events result in dead-end interactions between the novel IAVs and the animals (grey dashed lines, H5N1 in dairy cattle requires further studies), but some subtypes successfully circulate within that animal population (bolded red). These cross-species transmissions can also occur between animals and humans, raising public health risks (blue dashed lines). The host-adapted changes in animal-isolated IAVs are summarized below the host species.
Figure 1. Cross-species transmission of influenza A virus. From their natural reservoirs in wild waterfowl, influenza A viruses (IAVs) have been transmitted to various animal species. The majority of these cross-species transmission events result in dead-end interactions between the novel IAVs and the animals (grey dashed lines, H5N1 in dairy cattle requires further studies), but some subtypes successfully circulate within that animal population (bolded red). These cross-species transmissions can also occur between animals and humans, raising public health risks (blue dashed lines). The host-adapted changes in animal-isolated IAVs are summarized below the host species.
Viruses 16 01129 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lee, C.-Y. Exploring Potential Intermediates in the Cross-Species Transmission of Influenza A Virus to Humans. Viruses 2024, 16, 1129. https://doi.org/10.3390/v16071129

AMA Style

Lee C-Y. Exploring Potential Intermediates in the Cross-Species Transmission of Influenza A Virus to Humans. Viruses. 2024; 16(7):1129. https://doi.org/10.3390/v16071129

Chicago/Turabian Style

Lee, Chung-Young. 2024. "Exploring Potential Intermediates in the Cross-Species Transmission of Influenza A Virus to Humans" Viruses 16, no. 7: 1129. https://doi.org/10.3390/v16071129

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop